Tsutomu Kobayashi

13PUBLICATIONS
31CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 20, 2025
Impact of Achieving Progression-Free Survival 24 on Subsequent Overall Survival in Diffuse Large B-Cell Lymphoma Patients.

Ayumi Fujimoto, Wataru Munakata, Gakuto Ogawa

|Feb 25, 2025
Obinutuzumab maintenance versus observation for patients with newly diagnosed high tumor burden follicular lymphoma who achieved complete metabolic response after obinutuzumab plus bendamustine induction therapy: a multicenter, randomized, phase III study (JCOG2008, MAIN study).

Tsutomu Kobayashi, Kenichi Ishizawa, Ryunosuke Machida

|Feb 16, 2023
Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.

Naoko Hosono, SungGi Chi, Takahiro Yamauchi

|Feb 01, 2023
Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti-SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms.

Akio Onishi, Yayoi Matsumura-Kimoto, Shinsuke Mizutani

|Nov 23, 2022
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.

Tomotaka Suzuki, Dai Maruyama, Ryunosuke Machida

|Sep 13, 2022
Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective study.

Kentaro Mizuhara, Tsutomu Kobayashi, Mitsushige Nakao

Pageof 3

Frequent Collaborators

10 joint publications

Junya Kuroda

5 joint publications

Yuji Shimura

4 joint publications

Takahiro Fujino

3 joint publications

Dai Maruyama